Syncom Formulation P/E forward ratio data released

30 Jun 2026via TradingViewSource

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

Syncom Formulation P/E forward ratio data released.

The forward price-to-earnings ratio for Syncom Formulation (India) Ltd. has been updated on TradingView, reflecting market expectations. While no fundamental change in operations is indicated, the valuation metric may influence short-term trading sentiment. Traders may assess the stock against sector peers with average P/E around 28x.

📊 STOCKS: SYNCOMF | 🏢 SECTOR: Pharma | #LOWIMPACT #Valuation

#Valuation#P/E Ratio#SmallCap

Stocks mentioned

SYNCOMFSYNCOMF

⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.

Trade smarter on NSE

Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.

Start for ₹1 →